KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 0.01 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $81,942 | -18.9% | 7,745 | +23.0% | 0.00% | – |
| Q1 2022 | $101,000 | +65.6% | 6,296 | +93.0% | 0.00% | – |
| Q3 2021 | $61,000 | +8.9% | 3,263 | +21.9% | 0.00% | – |
| Q2 2021 | $56,000 | -26.3% | 2,676 | 0.0% | 0.00% | – |
| Q1 2021 | $76,000 | -78.6% | 2,676 | -75.3% | 0.00% | -100.0% |
| Q4 2020 | $355,000 | +1167.9% | 10,855 | +1069.7% | 0.00% | – |
| Q3 2020 | $28,000 | -44.0% | 928 | -70.0% | 0.00% | – |
| Q2 2020 | $50,000 | +177.8% | 3,091 | +72.2% | 0.00% | – |
| Q1 2020 | $18,000 | -48.6% | 1,795 | -29.7% | 0.00% | – |
| Q4 2019 | $35,000 | +218.2% | 2,552 | +235.3% | 0.00% | – |
| Q4 2018 | $11,000 | -15.4% | 761 | +0.5% | 0.00% | – |
| Q3 2018 | $13,000 | +18.2% | 757 | +24.7% | 0.00% | – |
| Q2 2018 | $11,000 | +10.0% | 607 | +9.8% | 0.00% | – |
| Q1 2018 | $10,000 | – | 553 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 1,849,947 | $16,871,517 | 9.37% |
| Prosight Management, LP | 1,932,456 | $17,623,999 | 5.58% |
| ACUTA CAPITAL PARTNERS, LLC | 702,093 | $6,403,088 | 4.29% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 350,445 | $3,196,058 | 3.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,335,845 | $66,902,906 | 3.62% |
| Affinity Asset Advisors, LLC | 856,535 | $7,811,599 | 2.20% |
| TCG Crossover Management, LLC | 1,423,642 | $12,983,615 | 1.91% |
| EcoR1 Capital, LLC | 5,806,871 | $52,958,664 | 1.79% |
| BVF INC/IL | 6,730,983 | $61,386,565 | 1.66% |
| DAFNA Capital Management LLC | 550,784 | $5,023,150 | 1.56% |